[Real world study and its application in gastrointestinal stromal tumor]

Area of Science:

• Oncology
• Gastroenterology
• Real-World Evidence

Background:

• Gastrointestinal stromal tumors (GIST) are rare, making randomized controlled trials (RCTs) challenging due to small participant numbers.
• Real-world study (RWS) complements traditional RCTs by utilizing real-world data (RWD) for deeper insights into treatment efficacy and patient populations.

Purpose of the Study:

• To highlight the growing importance and applications of RWS in understanding GIST.
• To outline how RWS aids in diagnosis, treatment, prognosis, and outcome prediction for GIST patients.

Main Methods:

• RWS leverages diverse real-world data sources to analyze GIST diagnosis, treatment effectiveness, safety, prognosis, and cost-effectiveness.
• Focus on diagnostic accuracy, therapeutic evaluation, prognostic factor identification, and predictive modeling for GIST.

Main Results:

• RWS provides crucial evidence for clarifying the best use of treatments for individual and population-level GIST care.
• Pharmacoeconomic RWS can guide optimal healthcare resource allocation for GIST treatments.

Conclusions:

• High-quality RWS for GIST requires attention to data sources, data quality, statistical expertise, and standardized processes.
• RWS is essential for advancing the understanding and management of GIST in clinical practice.